<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Novartis (Web)</title><link>http://www.zibb.com/all/theme/cq/Novartis</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Novartis" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Tue, 24 Nov 2009 05:01:22 GMT</pubDate><lastBuildDate>Tue, 24 Nov 2009 05:01:22 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Novartis (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Novartis</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>SC issues notices to Centre, others on Novartis plea</title><link>http://www.thehindubusinessline.com/blnus/28111320.htm</link><description>NEW DELHI: The Supreme Court on Friday issued notices to the Centre, pharma major Cipla, Ranbaxy Lab, Hetero Drugs, Natco Pharma and others on a pettion filed by Swiss firm Novartis AG challenging the denial of patent for its blood cancer drug Glivec in beta crystal form.</description><guid>http://www.thehindubusinessline.com/blnus/28111320.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.thehindubusinessline.com" /></item><item><title>Novartis Pharmaceuticals Corporation</title><link>http://www.pharma.us.novartis.com/</link><description>For the third year in a row, Novartis Pharmaceuticals Corporation has been recognized by Diversity Inc, a leading publication on diversity and business, as one of the Top 50 Companies for Diversity in the US.</description><guid>http://www.pharma.us.novartis.com/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.pharma.us.novartis.com" /></item><item><title>Novartis Institutes for BioMedical Research - 10006343 - New Scie...
      </title><link>http://www.newscientistjobs.com/jobs/organisationprofile/science--novartis_institutes_for_biomedical_research-10006343.htm</link><description>Read the recruiter profile for Novartis Institutes for BioMedical Research. Visit New Scientist Jobs for jobs from Novartis Institutes for BioMedical Research.</description><guid>http://www.newscientistjobs.com/jobs/organisationprofile/science--novartis_institutes_for_biomedical_research-10006343.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.newscientistjobs.com" /></item><item><title>Novartis Enters Into Agreement for Exclusive US and Canadian Righ...
      </title><link>http://www.bio-medicine.org/medicine-technology-1/Novartis-Enters-Into-Agreement-for-Exclusive-US-and-Canadian-Rights-to-Fanapt-28TM-29--an-FDA-Approved-Oral-Therapy-for-Schizophrenia-5408-1/</link><description>...EAST HANOVER N.J. Oct. 12 /- Novartis Pharma ...As part of the agreement with Vanda Pharmaceuticals Inc. Novartis wil...Schizophrenia is a severe psychiatric disorder that is estimated to af... Schizophrenia remains one of the most chronic and debilitating of</description><guid>http://www.bio-medicine.org/medicine-technology-1/Novartis-Enters-Into-Agreement-for-Exclusive-US-and-Canadian-Rights-to-Fanapt-28TM-29--an-FDA-Approved-Oral-Therapy-for-Schizophrenia-5408-1/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Mon, 12 Oct 2009 11:07:10 GMT</pubDate><source url="http://www.bio-medicine.org" /></item><item><title>Welcome to Novartis Animal Health - Novartis.com</title><link>http://www.ah.novartis.com/</link><description>Novartis Animal Health is dedicated to maintaining and improving the health and welfare of animals, both pets and farm animals. We research, develop and commercialize leading animal treatments that meet the needs of pet owners, farmers and veterinarians.</description><guid>http://www.ah.novartis.com/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.ah.novartis.com" /></item><item><title>Novartis (MP) - 20000941 - Personneltoday Jobs</title><link>http://www.personneltoday.com/jobs/promoteorganisationprofile/hr--novartis_mp-20000941.htm</link><description>Add a simple job widget to your website, web page or blog and allow your visitors to see the latest jobs from this organisation. Get the code now - it's free and there's no registration.</description><guid>http://www.personneltoday.com/jobs/promoteorganisationprofile/hr--novartis_mp-20000941.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.personneltoday.com" /></item><item><title>VNDA: License Agreement w/Novartis re Fanapt(TM) for Schizophreni...
      </title><link>http://www.zibb.com/article/5585887/VNDA+License+Agreement+w+Novartis+re+Fanapt+TM+for+Schizophrenia</link><description>By Fain Hughes, fhughes@knobias.com Vanda Pharmaceuticals Inc. (VNDA) has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. FDA on May 6, 2009 for the acute</description><guid>http://www.zibb.com/article/5585887/VNDA+License+Agreement+w+Novartis+re+Fanapt+TM+for+Schizophrenia</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Tue, 13 Oct 2009 08:19:19 GMT</pubDate><source url="http://www.zibb.com" /></item><item><title>Novartis UK Home Page</title><link>http://www.novartis.co.uk/</link><description>Novartis UK is the UK affiliate of Swiss based Novartis AG – one of the largest and most widely respected pharmaceutical companies in the world. This pioneering and innovative company came about through the merger, in 1996, of two key Swiss pharmaceutical organisations, Ciba Geigy and Sandoz.</description><guid>http://www.novartis.co.uk/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.novartis.co.uk" /></item><item><title>India rejects Novartis challenge : The Lancet Infectious Diseases</title><link>http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(07)70202-5</link><description>The High Court in Chennai, India, has agreed to uphold India's Patent Act in the face of a challenge by Swiss pharmaceutical company Novartis, in a court case that has been ongoing since January.</description><guid>http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(07)70202-5</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.thelancet.com" /></item><item><title>Pediatric Exclusivity Granted</title><link>http://www.fda.gov/cder/pediatric/exgrant.htm</link><description>This list simply identifies approved active moieties with sponsors to which FDA has granted exclusivity for pediatric studies. Only applications held by the identified sponsor were granted pediatric exclusivity.</description><guid>http://www.fda.gov/cder/pediatric/exgrant.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Wed, 06 May 2009 12:00:00 GMT</pubDate><source url="http://www.fda.gov" /></item><item><title>Novartis Medical Nutrition Homepage - Novartis.com</title><link>http://www.novartisnutrition.com/</link><description>for millions of patients and consumers who use our range of tube and oral nutrition brands and devices in healthcare delivery settings (hospitals, nursing homes and home healthcare) or independently at home.</description><guid>http://www.novartisnutrition.com/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.novartisnutrition.com" /></item><item><title>Target ID and Validation for Orphan Diseases</title><link>http://www.dddmag.com/target-id-and-validation-for-orphan.aspx</link><description>Diseases such as malaria and dengue fever may not get the attention they deserve, but academic researchers and some companies are trying to change that</description><guid>http://www.dddmag.com/target-id-and-validation-for-orphan.aspx</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.dddmag.com" /></item><item><title>RAD001 - Anti-Cancer Therapy</title><link>http://www.drugdevelopment-technology.com/projects/rad001/</link><description>RAD001 (everolimus) is a macrolide antibiotic derived from rapamycin that is being investigated by Novartis as a potential treatment for various solid tumours, including advanced kidney cancer. Rapamycin is an interesting drug because of its diverse clinical applications.</description><guid>http://www.drugdevelopment-technology.com/projects/rad001/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Thu, 17 Jul 2008 00:00:00 GMT</pubDate><source url="http://www.drugdevelopment-technology.com" /></item><item><title>Eye Health information from Alcon</title><link>http://www.alconinc.com/</link><description>Every day, we challenge ourselves with Alcon's mission – to help people worldwide see better. As the leader in eye care, this mission means that we strive to make significant contributions in the fight to prevent and, one day, eliminate blindness.</description><guid>http://www.alconinc.com/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.alconinc.com" /></item><item><title>Freelance Data Migration Consultant | Sutton, Surrey, UK | £83.33...
      </title><link>http://www.people4business.com/seller-272733.htm</link><description>Freelance Data Migration Consultant | Sutton, Surrey, UK | £83.33 per hour | SAP Data Migration consultantSAP ABAP/Workflow consultant with more than 9 years experience in developing and implementing SAP Workflow and ABAP solutions.Involved in 4 full cycle im</description><guid>http://www.people4business.com/seller-272733.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.people4business.com" /></item><item><title>Novartis Biomanufacturing Plant,</title><link>http://www.pharmaceutical-technology.com/projects/novartisbio/</link><description>Novartis is a multinational pharmaceutical company, based in Basel in Switzerland. The company has plants situated across the world but is developing a particularly strong presence in Asia, with its Asia Pacific HQ in Singapore.</description><guid>http://www.pharmaceutical-technology.com/projects/novartisbio/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Thu, 28 Feb 2008 00:00:00 GMT</pubDate><source url="http://www.pharmaceutical-technology.com" /></item><item><title>Novartis Ophthalmics Canada - Bienvenue - Welcome</title><link>http://www.novartisophthalmics.ca/</link><description>L'information contenue dans ce site Web s'adresse uniquement aux résidents du Canada.</description><guid>http://www.novartisophthalmics.ca/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.novartisophthalmics.ca" /></item><item><title>Kellerhals Hess, Attorneys-at-Law - Kellerhals Hess, Attorneys-at...
      </title><link>http://www.martindale.com/Kellerhals-Hess-Attorneys-at-Law/law-firm-1043372.htm</link><description>Browse the Kellerhals Hess, Attorneys-at-Law law firm overview by Martindale-Hubbell. The Kellerhals Hess, Attorneys-at-Law law firm overview page contains articles peer review ratings and client reviews.</description><guid>http://www.martindale.com/Kellerhals-Hess-Attorneys-at-Law/law-firm-1043372.htm</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.martindale.com" /></item><item><title>[video] 3 Stocks I Saw on TV (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=1259bnkis/*http://www.thestreet.com/_yahoo/video/strategysession/10440352.html?cm_ven=YAHOOV&amp;cm_cat=FREE&amp;cm_ite=NA</link><description>Dan Fitzpatrick examines three stocks viewed on FastMoney. Today's stocks include National City, Novartis and McDonalds.</description><guid>http://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=1259bnkis/*http://www.thestreet.com/_yahoo/video/strategysession/10440352.html?cm_ven=YAHOOV&amp;cm_cat=FREE&amp;cm_ite=NA</guid><category domain="http://www.zibb.com">Novartis</category><pubDate>Thu, 02 Oct 2008 12:08:25 GMT</pubDate><source url="http://us.rd.yahoo.com" /></item><item><title>Apria - resources - News</title><link>http://www.apria.com/resources/1,2725,494-863228,00.html</link><description>WASHINGTON, Dec 19 (Reuters) - U.S. health regulators have approved Novartis' drug Gleevac to reduce the risk of cancer recurring in patients with a rare type of stomach cancer, Novartis said on Friday.</description><guid>http://www.apria.com/resources/1,2725,494-863228,00.html</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.apria.com" /></item><item><title>Will Pfizer's Merger Hurt Innovation? - Forbes.com</title><link>http://www.forbes.com/2009/01/26/pfizer-wyeth-pharmacuticals-biz-healthcare-cx_mh_0126pfizer.html</link><description>Pfizer's $68 billion takeout of smaller rival Wyeth? Listen to what William Steere, Pfizer's chief executive, had to say a decade ago: "Mergers in this industry are done out of weakness. We're not weak."</description><guid>http://www.forbes.com/2009/01/26/pfizer-wyeth-pharmacuticals-biz-healthcare-cx_mh_0126pfizer.html</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.forbes.com" /></item><item><title>Novartis | Company Information from ICIS</title><link>http://www.icis.com/v2/companies/9146082/Novartis.html</link><description>Novartis is a pharmaceuticals, consumer health, generics, eye-care, and animal health company. Its main business units are Pharmaceuticals, Vaccines and Diagnostics, Sandoz and Consumer Health. Novartis key contacts and Novartis key personnel can be found here.</description><guid>http://www.icis.com/v2/companies/9146082/Novartis.html</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.icis.com" /></item><item><title>GPC-Biotech</title><link>http://www.gpc-biotech.com/en/about_the_company/management_board/</link><description>From 1992 to 1996, Dr. Seizinger was at Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, New Jersey, where he held the posts of Vice President of Oncology Drug Discovery and, in parallel, Vice President of Corporate and Academic Alliances. From 1984 to 1992, Dr.</description><guid>http://www.gpc-biotech.com/en/about_the_company/management_board/</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.gpc-biotech.com" /></item><item><title>PHARMACOKINETIC / PHARMACODYNAMIC RELATIONSHIPS OF TIAMULIN (DENA...
      </title><link>http://www.pigprogress.net/public/file/IPVS-oral%20presentations/Bacterial%20Diseases/Lawsonia/Pharmacokinetic-pharmacodynamic%20relationships%20of%20tiamulin%20(Denagard)%20for%20proliferative%20enteropathy%20(ileitis).pdf</link><description>It was the purpose of this paper to look at the pharmacokinetics (PK) of tiamulin (THF) in the gut contents and relate these to the pharmacodynamics (PD) of Li and also the clinical effect.</description><guid>http://www.pigprogress.net/public/file/IPVS-oral%20presentations/Bacterial%20Diseases/Lawsonia/Pharmacokinetic-pharmacodynamic%20relationships%20of%20tiamulin%20(Denagard)%20for%20proliferative%20enteropathy%20(ileitis).pdf</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.pigprogress.net" /></item><item><title>Fly Control</title><link>http://www.farmrite.co.uk/category.ds2?ba=105131&amp;c=60</link><description>Youngs Crovect Pouron 2.2 ltr Pour on containing 1.25% w/v high-cis cypermethrin for the prevention and treatment of blowfly strike in sheep. Prevention...</description><guid>http://www.farmrite.co.uk/category.ds2?ba=105131&amp;c=60</guid><category domain="http://www.zibb.com">Novartis</category><pubDate /><source url="http://www.farmrite.co.uk" /></item></channel></rss>